MARIA YOLANDA DIEBOLD LUQUE-rekin lankidetzan egindako argitalpenak (30)

2014

  1. CD44 and RHAMM hyaluronan receptors in human ocular surface inflammation

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 252, Núm. 8, pp. 1289-1295

2010

  1. Applications of nanoparticles in ophthalmology

    Progress in Retinal and Eye Research, Vol. 29, Núm. 6, pp. 596-609

  2. Dry eye disease as an inflammatory disorder

    Ocular Immunology and Inflammation, Vol. 18, Núm. 4, pp. 244-253

  3. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles

    Cornea, Vol. 29, Núm. 5, pp. 550-558

2008

  1. Chitosan-Based Colloidal Systems as Promising Topical Drug Carriers for Ocular Surface Disorders

    PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS

  2. Cytokine responses by conjunctival epithelial cells: An in vitro model of ocular inflammation

    Cytokine, Vol. 44, Núm. 1, pp. 160-167

2007

  1. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)

    Biomaterials, Vol. 28, Núm. 8, pp. 1553-1564

2005

  1. Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium

    Investigative Ophthalmology and Visual Science, Vol. 46, Núm. 2, pp. 504-513

  2. α2-adrenergic receptors are present in normal human conjunctiva

    Current Eye Research, Vol. 30, Núm. 12, pp. 1121-1129

2004

  1. Impression cytology of the ocular surface: A review

    Experimental Eye Research, Vol. 78, Núm. 3, pp. 457-472